Rubric Capital Management (New York)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rubric Capital Management (New York)’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-59,306	Closed	-$2.49M	–	69
2020 Q1	$2.49M	Buy	+59,306	New	+$2.72M	0.39%	46
2019 Q2	–	Sell	-857,103	Closed	-$38.4M	–	76
2019 Q1	$38.4M	Buy	857,103 +213,706	+33%	+$9.8M	3.59%	6
2018 Q4	$25.1M	Buy	+643,397	New	+$25.3M	3.1%	13

Other funds holding ARNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rubric Capital Management (New York)'s ARNA Position: Q2 2020 in Review

Rubric Capital Management (New York) sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 59,306 shares — an estimated $2.49M sold.

Rubric Capital Management (New York) first reported a position in ARNA in Q4 2018 and held it in 3 quarters. The position peaked at $38.4M in Q1 2019. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

Rubric Capital Management (New York) reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Rubric Capital Management (New York) sold 59,306 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $2.49M.
Rubric Capital Management (New York) first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 3 quarters.
Rubric Capital Management (New York)'s Arena Pharmaceuticals Inc position peaked at $38.4M in Q1 2019.
247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2020, filed 10 Aug 2020.